BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UM//UM*Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Detroit
TZURL:http://tzurl.org/zoneinfo/America/Detroit
X-LIC-LOCATION:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20070311T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20071104T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20250107T124348
DTSTART;TZID=America/Detroit:20250109T153000
DTEND;TZID=America/Detroit:20250109T163000
SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series
DESCRIPTION:Abstract:\nAs engineers\, we are constantly seeking to improve the world around us with effective and clever solutions to our chosen problems. Healthcare is an essential aspect of our lives\, though with patient safety\, positive clinical outcomes\, and cost-efficiency as paramount. These sometimes opposing aims can be unified through patient- and outcomes-focused clinical translational research to reimagine and advance the standard of care.\n\nThis talk will discuss the application of real-time\, label-free\, noninvasive optical or biophotonics-based diagnostic approaches\, like optical coherence tomography and nonlinear imaging\, to capture patient-specific assessment of ‘the state of the tissue’ - structure and function under normal and diseased conditions. Using these diagnostic tools as part of a control or feedback loop\, the therapeutic parameter space (frequency\, dose strength\, interval\, etc.) for emerging treatment approaches can be observed and optimized.\n\nSeveral examples to improve health outcomes through development and application of this combined assessment and therapeutic pipeline will be presented. In neuromodulation\, there is a need to assess device safety and efficacy to meet regulatory performance metrics. For surgical technology\, reducing cancer re-excision rates can benefit from real-time identification of tissue margins. In middle ear disease\, the diagnostic standard can be improved to ensure standard of care treatments are delivered as accurately as possible. Looking towards the future\, the assessment and treatment of otitis media and other diseases can be transformed by developing plasma medicine and other emerging therapeutic approaches to reduce pathogenic load and cure disease without using antibiotics.
UID:130551-21866255@events.umich.edu
URL:https://events.umich.edu/event/130551
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Bioninterfaces,seminar,Science,Michigan Engineering,Medicine,engineering,engineer,bme,Biotechnology,Biosciences,biomedical engineering,biomedical,Biology,Biointerfaces
LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20250107T121641
DTSTART;TZID=America/Detroit:20250109T160000
DTEND;TZID=America/Detroit:20250109T190000
SUMMARY:Performance:Concerto Competition: Graduate Finalists
DESCRIPTION:Winners of the SMTD Concerto Competition will perform their competition piece with one of the School’s orchestras in an upcoming performance at Hill Auditorium.
UID:122644-21849490@events.umich.edu
URL:https://events.umich.edu/event/122644
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Concert,Music,Free
LOCATION:Hill Auditorium
CONTACT:
END:VEVENT
END:VCALENDAR